bs-2499R-Cy5 [Conjugated Primary Antibody]
CD69 Polyclonal Antibody, Cy5 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: CD69/CLEC2C/AIM

Immunogen Range: 101-199/199


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 969

Swiss Prot: Q07108

Source: KLH conjugated synthetic peptide derived from human CD69

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.

Conjugation: Cy5

Excitation/ Emission: 625,650nm/670nm

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
FCM(1:20-100)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 22


Cross Reactive Species: Human
Mouse

Predicted Cross Reactive Species: Rat
Dog

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Mokuda et al. CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis. (2015) Arthritis.Res.Ther. 17:275Read more>>
  • Liu S et al. Structural characterization of a novel polysaccharide from Panax notoginseng residue and its immunomodulatory activity on bone marrow dendritic cells. Int J Biol Macromol. 2020 Oct 15;161:797-809.Read more>>
  • Rouven Hoefflin. et al. HIF-1 and HIF-2 differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice. Nat Commun. 2020 Aug;11(1):1-21Read more>>
  • Zihuan Luo. et al. Ex vivo anchored PD-L1 functionally prevent in vivo renal allograft rejection. BIOENG TRANSL MED. 2022 Apr 06Read more>>
  • Hashimoto Masashi. et al. Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. BRIT J CANCER. 2024 Feb;:1-9Read more>>
VALIDATION IMAGES